Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure

This study examined the independent relation of health-related quality of life (HRQL) to mortality and congestive heart failure (CHF)-related hospitalizations in patients with an ejection fraction of

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 1996-10, Vol.78 (8), p.890-895
Hauptverfasser: Konstam, Varda, Salem, Deeb, Pouleur, Hubert, Kostis, John, Gorkin, Larry, Shumaker, Sally, Mottard, Isabelle, Woods, Pat, Konstam, Marvin A., Yusuf, Salim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 895
container_issue 8
container_start_page 890
container_title The American journal of cardiology
container_volume 78
creator Konstam, Varda
Salem, Deeb
Pouleur, Hubert
Kostis, John
Gorkin, Larry
Shumaker, Sally
Mottard, Isabelle
Woods, Pat
Konstam, Marvin A.
Yusuf, Salim
description This study examined the independent relation of health-related quality of life (HRQL) to mortality and congestive heart failure (CHF)-related hospitalizations in patients with an ejection fraction of
doi_str_mv 10.1016/S0002-9149(96)00463-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_230374251</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914996004638</els_id><sourcerecordid>10415974</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-3846b8bd9712a375a2b44c9fa36de836e6923af1fd2f6e303441772e255bf6e93</originalsourceid><addsrcrecordid>eNqFkF1rFDEUhoMouFZ_ghDECwsdzfdMrsQu1hW2WFHxMpzNnGjKOFmTbLH99Wa7pbe9Cu_hOR95CHnJ2VvOuHn3jTEmOsuVfWPNMWPKyG54RBZ86G3HLZePyeIeeUqelXLZIufaLMi_Uyg4xRnp1x1MsV7TFOg6BqRQKNCLjGP0NeV9-TzlemBgHukqlW3c5xuoMc00zlSfMKHpRcs410J_xvqbLtP8C0uNV0hXCLnSM4jTLuNz8iTAVPDF3XtEfpx9_L5cdesvnz4vP6w7r7iunRyU2Qyb0fZcgOw1iI1S3gaQZsRBGjRWSAg8jCIYlEwqxfteoNB60wpWHpFXh7nbnP7u2iXuMu3y3FY60fBeCc0bpA-Qz6mUjMFtc_wD-dpx5vaO3a1jtxforHG3jt3Q-l7fDYfiYQoZZh_LfbMUuhdaNuz9AcP20auI2RXfFPnmNqOvbkzxgUX_AfVhj1E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230374251</pqid></control><display><type>article</type><title>Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure</title><source>Elsevier ScienceDirect Journals</source><creator>Konstam, Varda ; Salem, Deeb ; Pouleur, Hubert ; Kostis, John ; Gorkin, Larry ; Shumaker, Sally ; Mottard, Isabelle ; Woods, Pat ; Konstam, Marvin A. ; Yusuf, Salim</creator><creatorcontrib>Konstam, Varda ; Salem, Deeb ; Pouleur, Hubert ; Kostis, John ; Gorkin, Larry ; Shumaker, Sally ; Mottard, Isabelle ; Woods, Pat ; Konstam, Marvin A. ; Yusuf, Salim ; SOLVD Investigators ; </creatorcontrib><description><![CDATA[This study examined the independent relation of health-related quality of life (HRQL) to mortality and congestive heart failure (CHF)-related hospitalizations in patients with an ejection fraction of <0.35 followed for a mean of 36.5 months. A brief HRQL questionnaire was administered at baseline to patients randomized to placebo or enalapril in the Studies of Left Ventricular Dysfunction (SOLVD) trial. Participants had an ejection fraction of <0.35 and either symptomatic CHF (treatment trial, n = 2,465) or asymptomatic CHF (prevention trial, n = 2,560). Baseline assessment of HRQL predicted mortality and CHF-related hospitalizations in symptomatic and asymptomatic patients randomized to enalapril and placebo treatment. Domains that were the stronger univariate predictors of mortality and CHF-related hospitalizations were activities of daily living (relative risk [RR] for mortality: 1.163, p <0.000; for hospitalization: 1.215, p <0.000), general health (RR for mortality: 1.205, p <0.000; for hospitalization: 1.188, p <0.000), and social functioning (RR for mortality 1.098, p <0.000; for hospitalization: RR 1.156, p <0.000). In the multivariate model, activities of daily living (RR for mortality 1.41, p <0.000; for hospitalization: RR 1.43, p <0.002), general health (RR for mortality 1.21, p <0.000; for hospitalization RR 1.16, p <0.013) and heart failure symptoms (RR for mortality 1.02, p <0.025; for hospitalization RR 1.03, p <0.004) were found to be independent risk factors. HRQL independently predicted mortality and CHF-related hospitalizations after adjustment for ejection fraction, age, treatment, and New York Heart Association classification in patients with an ejection fraction of <0.35, randomized to enalapril and placebo treatment. HRQL provides additional clinical information regarding disease course and outcome that is not captured by traditional indexes of clinical status. (Am J Cardiol 1996;78:890–895)]]></description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/S0002-9149(96)00463-8</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Biological and medical sciences ; Cardiology. Vascular system ; Cardiovascular disease ; Health ; Heart ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Medical sciences ; Mortality ; Quality of life</subject><ispartof>The American journal of cardiology, 1996-10, Vol.78 (8), p.890-895</ispartof><rights>1996 Excerpta Medica Inc.</rights><rights>1996 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Oct 15, 1996</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-3846b8bd9712a375a2b44c9fa36de836e6923af1fd2f6e303441772e255bf6e93</citedby><cites>FETCH-LOGICAL-c415t-3846b8bd9712a375a2b44c9fa36de836e6923af1fd2f6e303441772e255bf6e93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002914996004638$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3257253$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Konstam, Varda</creatorcontrib><creatorcontrib>Salem, Deeb</creatorcontrib><creatorcontrib>Pouleur, Hubert</creatorcontrib><creatorcontrib>Kostis, John</creatorcontrib><creatorcontrib>Gorkin, Larry</creatorcontrib><creatorcontrib>Shumaker, Sally</creatorcontrib><creatorcontrib>Mottard, Isabelle</creatorcontrib><creatorcontrib>Woods, Pat</creatorcontrib><creatorcontrib>Konstam, Marvin A.</creatorcontrib><creatorcontrib>Yusuf, Salim</creatorcontrib><creatorcontrib>SOLVD Investigators</creatorcontrib><title>Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure</title><title>The American journal of cardiology</title><description><![CDATA[This study examined the independent relation of health-related quality of life (HRQL) to mortality and congestive heart failure (CHF)-related hospitalizations in patients with an ejection fraction of <0.35 followed for a mean of 36.5 months. A brief HRQL questionnaire was administered at baseline to patients randomized to placebo or enalapril in the Studies of Left Ventricular Dysfunction (SOLVD) trial. Participants had an ejection fraction of <0.35 and either symptomatic CHF (treatment trial, n = 2,465) or asymptomatic CHF (prevention trial, n = 2,560). Baseline assessment of HRQL predicted mortality and CHF-related hospitalizations in symptomatic and asymptomatic patients randomized to enalapril and placebo treatment. Domains that were the stronger univariate predictors of mortality and CHF-related hospitalizations were activities of daily living (relative risk [RR] for mortality: 1.163, p <0.000; for hospitalization: 1.215, p <0.000), general health (RR for mortality: 1.205, p <0.000; for hospitalization: 1.188, p <0.000), and social functioning (RR for mortality 1.098, p <0.000; for hospitalization: RR 1.156, p <0.000). In the multivariate model, activities of daily living (RR for mortality 1.41, p <0.000; for hospitalization: RR 1.43, p <0.002), general health (RR for mortality 1.21, p <0.000; for hospitalization RR 1.16, p <0.013) and heart failure symptoms (RR for mortality 1.02, p <0.025; for hospitalization RR 1.03, p <0.004) were found to be independent risk factors. HRQL independently predicted mortality and CHF-related hospitalizations after adjustment for ejection fraction, age, treatment, and New York Heart Association classification in patients with an ejection fraction of <0.35, randomized to enalapril and placebo treatment. HRQL provides additional clinical information regarding disease course and outcome that is not captured by traditional indexes of clinical status. (Am J Cardiol 1996;78:890–895)]]></description><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular disease</subject><subject>Health</subject><subject>Heart</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Medical sciences</subject><subject>Mortality</subject><subject>Quality of life</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNqFkF1rFDEUhoMouFZ_ghDECwsdzfdMrsQu1hW2WFHxMpzNnGjKOFmTbLH99Wa7pbe9Cu_hOR95CHnJ2VvOuHn3jTEmOsuVfWPNMWPKyG54RBZ86G3HLZePyeIeeUqelXLZIufaLMi_Uyg4xRnp1x1MsV7TFOg6BqRQKNCLjGP0NeV9-TzlemBgHukqlW3c5xuoMc00zlSfMKHpRcs410J_xvqbLtP8C0uNV0hXCLnSM4jTLuNz8iTAVPDF3XtEfpx9_L5cdesvnz4vP6w7r7iunRyU2Qyb0fZcgOw1iI1S3gaQZsRBGjRWSAg8jCIYlEwqxfteoNB60wpWHpFXh7nbnP7u2iXuMu3y3FY60fBeCc0bpA-Qz6mUjMFtc_wD-dpx5vaO3a1jtxforHG3jt3Q-l7fDYfiYQoZZh_LfbMUuhdaNuz9AcP20auI2RXfFPnmNqOvbkzxgUX_AfVhj1E</recordid><startdate>19961015</startdate><enddate>19961015</enddate><creator>Konstam, Varda</creator><creator>Salem, Deeb</creator><creator>Pouleur, Hubert</creator><creator>Kostis, John</creator><creator>Gorkin, Larry</creator><creator>Shumaker, Sally</creator><creator>Mottard, Isabelle</creator><creator>Woods, Pat</creator><creator>Konstam, Marvin A.</creator><creator>Yusuf, Salim</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>19961015</creationdate><title>Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure</title><author>Konstam, Varda ; Salem, Deeb ; Pouleur, Hubert ; Kostis, John ; Gorkin, Larry ; Shumaker, Sally ; Mottard, Isabelle ; Woods, Pat ; Konstam, Marvin A. ; Yusuf, Salim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-3846b8bd9712a375a2b44c9fa36de836e6923af1fd2f6e303441772e255bf6e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular disease</topic><topic>Health</topic><topic>Heart</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Medical sciences</topic><topic>Mortality</topic><topic>Quality of life</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Konstam, Varda</creatorcontrib><creatorcontrib>Salem, Deeb</creatorcontrib><creatorcontrib>Pouleur, Hubert</creatorcontrib><creatorcontrib>Kostis, John</creatorcontrib><creatorcontrib>Gorkin, Larry</creatorcontrib><creatorcontrib>Shumaker, Sally</creatorcontrib><creatorcontrib>Mottard, Isabelle</creatorcontrib><creatorcontrib>Woods, Pat</creatorcontrib><creatorcontrib>Konstam, Marvin A.</creatorcontrib><creatorcontrib>Yusuf, Salim</creatorcontrib><creatorcontrib>SOLVD Investigators</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Konstam, Varda</au><au>Salem, Deeb</au><au>Pouleur, Hubert</au><au>Kostis, John</au><au>Gorkin, Larry</au><au>Shumaker, Sally</au><au>Mottard, Isabelle</au><au>Woods, Pat</au><au>Konstam, Marvin A.</au><au>Yusuf, Salim</au><aucorp>SOLVD Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure</atitle><jtitle>The American journal of cardiology</jtitle><date>1996-10-15</date><risdate>1996</risdate><volume>78</volume><issue>8</issue><spage>890</spage><epage>895</epage><pages>890-895</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract><![CDATA[This study examined the independent relation of health-related quality of life (HRQL) to mortality and congestive heart failure (CHF)-related hospitalizations in patients with an ejection fraction of <0.35 followed for a mean of 36.5 months. A brief HRQL questionnaire was administered at baseline to patients randomized to placebo or enalapril in the Studies of Left Ventricular Dysfunction (SOLVD) trial. Participants had an ejection fraction of <0.35 and either symptomatic CHF (treatment trial, n = 2,465) or asymptomatic CHF (prevention trial, n = 2,560). Baseline assessment of HRQL predicted mortality and CHF-related hospitalizations in symptomatic and asymptomatic patients randomized to enalapril and placebo treatment. Domains that were the stronger univariate predictors of mortality and CHF-related hospitalizations were activities of daily living (relative risk [RR] for mortality: 1.163, p <0.000; for hospitalization: 1.215, p <0.000), general health (RR for mortality: 1.205, p <0.000; for hospitalization: 1.188, p <0.000), and social functioning (RR for mortality 1.098, p <0.000; for hospitalization: RR 1.156, p <0.000). In the multivariate model, activities of daily living (RR for mortality 1.41, p <0.000; for hospitalization: RR 1.43, p <0.002), general health (RR for mortality 1.21, p <0.000; for hospitalization RR 1.16, p <0.013) and heart failure symptoms (RR for mortality 1.02, p <0.025; for hospitalization RR 1.03, p <0.004) were found to be independent risk factors. HRQL independently predicted mortality and CHF-related hospitalizations after adjustment for ejection fraction, age, treatment, and New York Heart Association classification in patients with an ejection fraction of <0.35, randomized to enalapril and placebo treatment. HRQL provides additional clinical information regarding disease course and outcome that is not captured by traditional indexes of clinical status. (Am J Cardiol 1996;78:890–895)]]></abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><doi>10.1016/S0002-9149(96)00463-8</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 1996-10, Vol.78 (8), p.890-895
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_journals_230374251
source Elsevier ScienceDirect Journals
subjects Biological and medical sciences
Cardiology. Vascular system
Cardiovascular disease
Health
Heart
Heart failure, cardiogenic pulmonary edema, cardiac enlargement
Medical sciences
Mortality
Quality of life
title Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T10%3A23%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Baseline%20Quality%20of%20Life%20as%20a%20Predictor%20of%20Mortality%20and%20Hospitalization%20in%205,025%20Patients%20With%20Congestive%20Heart%20Failure&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Konstam,%20Varda&rft.aucorp=SOLVD%20Investigators&rft.date=1996-10-15&rft.volume=78&rft.issue=8&rft.spage=890&rft.epage=895&rft.pages=890-895&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/S0002-9149(96)00463-8&rft_dat=%3Cproquest_cross%3E10415974%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=230374251&rft_id=info:pmid/&rft_els_id=S0002914996004638&rfr_iscdi=true